BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19520679)

  • 1. Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene mutations in a young patient on oral contraceptive pills: a case report.
    Charafeddine KM; Mahfouz RA; Ibrahim GY; Taher AT; Hoballah JJ; Taha AM
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):594-8. PubMed ID: 19520679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.
    Lenicek Krleza J; Jakovljevic G; Bronic A; Coen Herak D; Bonevski A; Stepan-Giljevic J; Roic G
    Pathophysiol Haemost Thromb; 2010; 37(1):24-9. PubMed ID: 20664190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
    Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
    Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis.
    Kupeli E; Verdi H; Simsek A; Atac FB; Eyuboglu FO
    Clin Appl Thromb Hemost; 2011; 17(6):E87-94. PubMed ID: 21078611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
    Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
    J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
    Kim RJ; Becker RC
    Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
    Eid SS; Rihani G
    Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence.
    Simsek E; Yesilyurt A; Pinarli F; Eyerci N; Ulus AT
    Gene; 2014 Feb; 536(1):171-6. PubMed ID: 24334115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.
    Al-Sweedan SA; Jaradat S; Iraqi M; Beshtawi M
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):675-8. PubMed ID: 19710606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial venous thrombosis: prevalence of common genetic risk factors and their role on spreading to deep veins.
    Milio G; Siragusa S; Minà C; Amato C; Corrado E; Grimaudo S; Novo S
    Thromb Res; 2008; 123(2):194-9. PubMed ID: 18387654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
    Ozmen F; Ozmen MM; Ozalp N; Akar N
    Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
    Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.